Evidence map›Paper›PMID 18719003›Full record

ArticlePhysical therapy2008

In vitro optimization of dexamethasone phosphate delivery by iontophoresis.

Jean-Philippe Sylvestre, Richard H Guy, M Begoña Delgado-Charro

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Physical therapy, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03636386 (Effectiveness of Percutaneous Microelectrolysis in the Decrease of Pain in Myofascial Trigger Points), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03636386 nacompletednot on this mapstarted 2018, after this paper: background citation

Effectiveness of Percutaneous Microelectrolysis in the Decrease of Pain in Myofascial Trigger Points: Evaluation Through Algometry and Visual Analog Scale. Randomized Controlled Trial.

TypeinterventionalSponsorQuiropraxia y EquilibrioRan2018 to 2019Enrolled48ConditionsMyofascial Trigger Point Pain (MTrP)ArmsPercutaneous microelectrolysis, Ultrasound therapy
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Iontophoresis of dexamethasone phosphate: competition with chloride ions.Journal of controlled release : official journal of the Controlled Release Society · 2008
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jean-Philippe SylvestreDepartment of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, United Kingdom.
Richard H Guy
M Begoña Delgado-Charro
University of Bath · GB

Funding

Skin Bioengineering: Noninvasive Transdermal MonitoringR01EB001420 · NIBIB · UNIVERSITY OF GENEVA · PI GUY, RICHARD H · 2003 to 2005
$729k
NIBIB NIH HHS EB-001420
6 · The paper itself

Abstract

background and purposeThis study was designed to evaluate the effects of competing ions and electroosmosis on the transdermal iontophoresis of dexamethasone phosphate (Dex-Phos) and to identify the optimal conditions for its delivery.

methodsThe experiments were performed using pig skin, in side-by-side diffusion cells (0.78 cm(2)), passing a constant current of 0.3 mA via Ag-AgCl electrodes. Dex-Phos transport was quantified for donor solutions (anodal and cathodal) containing different drug concentrations, with and without background electrolyte. Electrotransport of co-ion, citrate, and counterions Na(+) and K(+) also was quantified. The contribution of electroosmosis was evaluated by measuring the transport of the neutral marker (mannitol).

resultsElectromigration was the dominant mechanism of drug iontophoresis, and reduction in electroosmotic flow directed against the cathodic delivery of Dex-Phos did not improve drug delivery. The Dex-Phos flux from the cathode was found to be optimal (transport number of approximately 0.012) when background electrolyte was excluded from the formulation. In this case, transport of the drug is limited principally by the competition with counterions (mainly Na(+) with a transport number of approximately 0.8) and the mobility of the drug in the membrane. DISCUSSION AND

conclusionDex-Phos must be delivered from the cathode and formulated rationally, excluding mobile co-anions, to achieve optimal iontophoretic delivery.

Indexed as

IontophoresisAdministration, CutaneousAnimalsBiological TransportDexamethasoneElectroosmosisGlucocorticoidsSkinSwineTissue Culture TechniquesDexamethasoneGlucocorticoids

Identifiers

PMID18719003
PMCPMC2557054
OpenAlexW2146190709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.